Ireland· IE-PA-EU/1/24/1840/001-003
AKANTIOR 0.8 mg/mL eye drops, solution in single-dose container
A polihexanide product containing polihexanide, registered in Ireland by SIFI S.p.A.. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Polihexanide is registered in 9 of 19 countries.
Countries holding a registration under ATC S01AX24 (polihexanide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Polihexanide · ATC S01AX24
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Polihexanide
- Manufacturer
- SIFI S.p.A.
- Country
- Ireland (IE)
- ATC code
- S01AX24
- ATC class
- Polihexanide
- Defined daily dose
- 4 Eindosisbeh
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1840/001-003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polihexanide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKANTIORSIFI S.P.A., ACI SANT'ANTONIO (CT)
- BelgiumAkantior 0.8 mg/mlSIFI
- FinlandAKANTIORSIFI S.p.A. Via Ercole Patti, 36
- IcelandAKANTIORSIFI S.p.A.
- NetherlandsAKANTIOR 0,8 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikSIFI SpA
- SwedenAKANTIOR 0,8 mg/ml Ögondroppar, lösning i endosbehållareSIFI S.p.A.
- United KingdomAkantior 0.08% eye drops 0.3ml unit doseImported (Italy)
- SwitzerlandLavasept, gebrauchsfertige VerdünnungB. Braun Medical AG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Akantior
- Norway · Akantior
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b41a0b0-50fb-4ea3-977a-54e8682f7d2e GET /v1/drugs/2b41a0b0-50fb-4ea3-977a-54e8682f7d2e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S01AX24"
],
"strength": null,
"pa_number": "EU/1/24/1840/001-003",
"substances": [
"Polihexanide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "22/08/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about polihexanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.